Alzheimer's drug sparks hot debate over benefits as risks like brain bleeding emerge
Eisai Co. unveiled much-anticipated findings on its experimental Alzheimer's drug, providing tinder for the hot debate over whether its modest efficacy is worth potential risks that include serious brain bleeding.
Nov 30, 2022
0
11